Tech
Tech Industry Insights and Market Trends
CNBC's Jim Cramer discusses potential investment opportunities beyond artificial intelligence, suggesting a drug stock as a promising candidate for significant growth. The advice comes amid broader market trends and company-specific news.
Coverage timeline — 2 articles
CNBC
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
2026-10-26 17:00 UTC
New Scientist
Compared with humans, macaques are more likely to miss the bigger picture, but are also less confused by flipped images
2026-10-26 17:30 UTC